Skip to main content
. 2022 Jul 8;24(3):563. doi: 10.3892/etm.2022.11500

Figure 3.

Figure 3

Evaluation of the accuracy and sensitivity of LTBP2 as a biomarker for BCR of PCa. (A and C) ROC curve and its AUC value in (A) GEO-merged datasets and (C) validation dataset (GSE70769). (B and D) The relative expression levels of LTBP2 in (B) TCGA-PRAD dataset and (D) a validation dataset (GSE70769). LTBP2, latent transforming growth factor β-binding protein 2; BCR, biochemical recurrence; PCa, prostate cancer; ROC, receiver operating characteristic; AUC, area under the curve; GEO, Gene Expression Omnibus; TCGA, The Cancer Genome ATLAS; PRAD, prostate adenocarcinoma; Pri-, primary.